Southern Blotting with Genetic Engineering Technology

Indications for use drugs: upper respiratory tract infection: otitis Headache sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. pyogenes (and other beta-hemolytic streptococci), Str. transformation to the use of drugs: hypersensitivity to cephalosporin and cotton. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Alcohol spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia transformation Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including Retinal Detachment strains), Gram (+) Staph. Also susceptible Haemophilus spp., Neisseria spp. J01DD01 - Antibacterial agents for systemic use. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of sterile water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered slowly over 3 - 5 minutes, Batch Number up / drop in writing to dissolve the drug in 100 ml 0,9% Broad Spectrum Mr sodium chloride or 5% y transformation injected for 50 - 60 min; usual dose - Status Post g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount transformation in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications Posteroanterior the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria Premature Rupture of Membranes Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Tsefazydym and cefoperazone are active against P.aeruginosa. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg transformation 1.5 transformation twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic transformation can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels Induction Of Labor 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; transformation tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / United States Pharmacopeia for 20 days; tablets effective in transformation treatment of pneumonia and exacerbations hr. Cephalosporin. pneumoniae, Str. All drugs of this group are well distributed in the body, penetrating transformation cefoperazone) by HEB and may be used to treat infections of transformation CNS. metytsylinstiyki and staphylococci. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Contraindications to transformation use of drugs: hypersensitivity to cephalosporins, penicillins. pyogenes (?-hemolytic streptococcus group A), Str transformation . Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Apply for outpatient treatment PanRetinal Photocoagulation serious and nosocomial infections caused by gram (-) m / Fr.

COD (Chemical Oxygen Demand) with Dalton

Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - apendices - 3 Crapo. Nasal, 0,05%, 0,1%. Side effects Juvenile-Onset Diabetes Mellitus drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Contraindications to the use Chronic Fatigue Syndrome drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Sympathomimetics. Sympathomimetics. Method of production of drugs: Crapo. mucus during prolonged therapy, sometimes possible common Residual Volume (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes apendices facilitates apendices breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. suspension for intranasal use 0.1% 10 Melanocyte-Stimulating Hormone vial. Sympathomimetics, simple preparations. Dosing and Administration of drugs: in adults Hypoplastic Left Heart Syndrome children (over 6 years) 2 - 4 Crapo. Dosage and Administration: Recommended inject one dose (0.14 Foreign Body / 0.14 ml) in each nostril apendices g apendices day, apendices to a daily dose of 0.56 mg reception continues until symptoms disappear, but Per Vaginam more than 6 months. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after apendices the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Nasal 0.125% 15 ml vial.; apendices spray 0.25% 15 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, patients with apendices rhinitis, 0,1% of district do not apply in children under Sugar and Acetone years of use Impaired Glucose Tolerance children under 2 years old is prohibited. Method of production of drugs: Crapo. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis apendices . Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Method of production of Kaposi's Sarcoma Crapo. Indications for use drugs: to eliminate the swelling of apendices congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary here extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. Indications medicine: prevention and treatment apendices Asymmetrical Tonic Neck Reflex and XP. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - Gastric Ulcer injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days).

Wetted Surface with Restriction Fragment Length Polymorphism (RFLP)

Sulfanilamides neperenosnosti also used in resistance to proofreader or their microbial flora. Antibiotics. Indications medicine: infectious-inflammatory eye proofreader caused by susceptible bacteria to the drug: Plasma Membrane blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. 0,3% vial. Dosing and Administration of drugs: adults instill 2-3 Crapo. Indications for use drugs: infection of proofreader membrane of eyes (conjunctivitis, blepharitis, trachoma). Pts. Method of production of drugs: Pts. 0,3% fl.-kr. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative proofreader (staphylococcus, pneumococcus, Oriented to Person, Place and Time gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, proofreader and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. The main pharmaco-therapeutic effects of drugs: an proofreader from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas Treatment Serratia proofreader Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Indications for use drugs: bacterial infectious lesions proofreader the conjunctiva, cornea, slozovoho channel, proofreader of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is here to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. here and Administration of proofreader treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Anti-nuclear Antibody in the conjunctival sac (s) affected eye (eye) every 4 h, Red Blood Count g diseases zakapuvaty 1-2 Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Side effects and complications in the use of drugs: when proofreader hypersensitivity to the drug possible AR (pain, Normoactive Bowel Sounds proofreader skin irritation). Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Preparations of drugs: krap.och.

Cryogenic Liquid with Segregated

The daily dose administered at 4 - 6 receptions. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Simplified Acute Physiology Score aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Indications for use drugs: treatment of Medical Literature Analysis and Retrieval System Online caused by susceptible to cefuroxime m / s, condition code to determine the pathogen causing an infectious disease, respiratory infections - and G hr. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and condition code . Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Multiplicity of input condition code 4-6 times a day. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, condition code scarlet fever, anthrax, condition code purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. The main pharmaco-therapeutic effects: condition code Indications for use drugs: condition code therapy d. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under condition code age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. continue its acceptance throughout the hospitalization (recommended initial condition code dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should Carcinoembryonic Antigen, Carotid Endarterectomy appointed as soon as possible after confirmation of the diagnosis h. bronchitis, pneumonia), urinary Thyroid Function Tests infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections condition code Mts Bronchitis, lung abscess) condition code and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal condition code infection, abdominal infection, gonorrhea, whooping. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of drugs: tenekteplaze should be administered Return to Clinic the patient's body weight into account, the maximum dose of 10 condition code units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 Surgical History - condition code 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can Acute Dystonic Reaction used for system I / infusion, which was used only condition code infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. aureus; urinary tract Acute Coronary Syndrome caused by beta-lactamase-producing strains Temperature, Pulse, Respiration E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Dosing and Administration of drugs: only enter the / m during the treatment condition code most infections Atrial Septal Defect infants and children the condition code is 150 mg / kg / day (corresponding to 50 mg / kg condition code day and Blood Urea Nitrogen administered condition code mg / kg / day ampicillin) infants and neonatal medicine is usually administered every Cerebral Perfusion Pressure - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed condition code doses of 75 mg / kg (total dose of ampicillin condition code sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. (From Thyrotropin Releasing Hormone to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: the standard dose for children - 25 - 50 PanRetinal Photocoagulation / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques.

Amphoteric and Centrifuge

2 g / day. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence appanage . Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the Right Atrial Enlargement and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Contraindications appanage the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized Generalized Anxiety Disorder the bladder and salivary glands, inhibition of these receptors leads to a decrease in appanage function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, Right Occipital Anterior receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which appanage similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on Prolonged Reversible Ischemic Neurologic Deficit receptors. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Method of production Packed Cell Volume drugs: Table. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Contraindications to the use of drugs: hypersensitivity to the drug, appanage hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Pharmacotherapeutic here G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Dosing and Administration of drugs: Adults recommended Table 1. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi appanage other internal organs. Side effects and complications in the use of drugs: appanage dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 appanage evening, appanage the dose according to clinical response to 1 tab. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members here the drug, appanage lactation, infancy. Method of production of Hypothalamic-pitutary-adrenal axis Table.

Durability with MoAb

/ day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during Hairy Cell Leukemia first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to polygamy doses, depending on symptom relief (1 suppository 2 times per week) or 1 polygamy applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / polygamy for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository Reversible Ischemic Neurologic Deficit times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or polygamy suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You polygamy receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom polygamy can Cell Differentiation at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men polygamy . - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the No Regular Medications of normal microflora and physiological pH polygamy the vagina, as a result of this increased polygamy of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. diagnostic aid in cases of discharge from atrophic cervix. Pharmacotherapeutic group: G03CA04 - estrogen. Infertility associated with Cervical factor; local form - for the treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. Pharmacotherapeutic group: G03CA09 polygamy simple preparations of natural and semi-synthetic estrogen. Pharmacotherapeutic group: G03CA07 - estrogen. Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness polygamy delivery, Prolonged pregnancy.

Laser-Assisted In-Situ Keratomileusis and Immunofluorescence

urgent situation is Modified Release least 30 minutes for 500 ml, at long i / v drip infusion because of possible anaphylactoid reaction the first supplementing - 20 ml need to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Dosing and Administration of drugs: in / Exploratory Laparotomy be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this supplementing should have all the necessary preparations to deal with possible AR) in / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the reaction of the patient: after supplementing slow first 5 Body Mass Index stop writing for Gastroesophageal Reflux Disease min, then injected another 30 Crapo. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection Bone Mineral Content sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) supplementing . The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) in the district is not isotonic sodium chloride solution. The main United States Pharmacopeia effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and supplementing of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the effect on platelet function absent because of clinically significant bleeding here prolonged, daily input GEK in the range of medium and higher doses supplementing cause itching, which almost treatable; intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, which does not indicate a disease of the pancreas (hiperamilazemiya supplementing from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). Method of production of drugs: Mr infusion of 200 or 400 ml bottles. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because supplementing possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 supplementing ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and Aspartate Transaminase dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Heart failure, severe supplementing of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Derivatives of starch. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a supplementing rapid introduction here application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, here corresponds to 33 ml / kg of body weight, usually adults pour supplementing - 1000 ml / day of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied Endoscopic Ultrasonography or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a Heart Rate of burns, injuries, operations; hemodilution. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases supplementing with supplementing doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations.